213 related articles for article (PubMed ID: 3488951)
21. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
[TBL] [Abstract][Full Text] [Related]
22. Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?
Frödin JE; Faxas ME; Hagström B; Lefvert AK; Masucci G; Nilsson B; Steinitz M; Unger P; Mellstedt H
Hybridoma; 1991 Aug; 10(4):421-31. PubMed ID: 1937495
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.
Barel M; Fiandino A; Delcayre AX; Lyamani F; Frade R
J Immunol; 1988 Sep; 141(5):1590-5. PubMed ID: 2842398
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
Wagner UA; Oehr PF; Reinsberg J; Schmidt SC; Schlebusch HW; Schultes B; Werner A; Prietl G; Krebs D
Biotechnol Ther; 1992; 3(1-2):81-9. PubMed ID: 1305894
[TBL] [Abstract][Full Text] [Related]
25. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
[TBL] [Abstract][Full Text] [Related]
26. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
[TBL] [Abstract][Full Text] [Related]
27. Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.
Chakraborty M; Mukerjee S; Foon KA; Köhler H; Ceriani RL; Bhattacharya-Chatterjee M
Cancer Res; 1995 Apr; 55(7):1525-30. PubMed ID: 7533665
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer.
Tempero MA; Pour PM; Uchida E; Herlyn D; Steplewski Z
Hybridoma; 1986 Jul; 5 Suppl 1():S133-8. PubMed ID: 3744378
[TBL] [Abstract][Full Text] [Related]
29. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen.
Tsujisaki M; Hinoda Y; Tokuchi S; Hanzawa Y; Arimura Y; Masuya J; Kitagawa H; Okochi E; Shimamura T; Hamuro J
J Immunol; 1993 Jan; 150(2):508-16. PubMed ID: 8419483
[TBL] [Abstract][Full Text] [Related]
30. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
32. Human anti-murine immunoglobulin responses and immune functions in cancer patients receiving murine monoclonal antibody therapy.
Blottière HM; Steplewski Z; Herlyn D; Douillard JY
Hum Antibodies Hybridomas; 1991 Jan; 2(1):16-25. PubMed ID: 1908336
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
[TBL] [Abstract][Full Text] [Related]
34. Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma.
Herlyn D; Sears HF; Ernst CS; Iliopoulos D; Steplewski Z; Koprowski H
Am J Clin Oncol; 1991 Oct; 14(5):371-8. PubMed ID: 1951172
[TBL] [Abstract][Full Text] [Related]
35. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype.
Wettendorff M; Iliopoulos D; Schmoll E; Koprowski H; Herlyn D
J Immunol Methods; 1989 Jan; 116(1):105-15. PubMed ID: 2783712
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
Herlyn D; Wettendorff M; Koprowski H
Int Rev Immunol; 1989; 4(4):347-57. PubMed ID: 2519932
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients.
Blottière HM; Douillard JY; Koprowski H; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):1051s-1054s. PubMed ID: 2297720
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of colorectal cancer with monoclonal antibodies].
Nielsen SE
Ugeskr Laeger; 1997 May; 159(21):3134-9. PubMed ID: 9198999
[TBL] [Abstract][Full Text] [Related]
39. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Cheung NK; Guo HF; Heller G; Cheung IY
Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
[TBL] [Abstract][Full Text] [Related]
40. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]